Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Denali Therapeutics
Denali Therapeutics
Big Pharma Has Mad Love For These 2 Biotechs
Motley Fool
Fri, 10/11/19 - 10:41 pm
Big Pharma
biotechs
Regenxbio
Denali Therapeutics
Where Are They Now? Top 3 Biotech Startups From NextGen Bio Class of 2017
BioSpace
Tue, 03/5/19 - 10:05 am
Denali Therapeutics
C4 Therapeutics
Neon Therapeutics
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
Thu, 01/10/19 - 08:48 pm
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs
Xconomy
Thu, 11/1/18 - 12:22 pm
Sanofi
Denali Therapeutics
inflammation
Alzheimer's disease
R&D
Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox
Forbes
Fri, 10/26/18 - 09:58 am
Denali Therapeutics
Michael J Fox
Parkinson's Disease
As a new study spotlights a growing role for LRRK2 in Parkinson’s, Denali clears an early trial hurdle
Endpoints
Thu, 08/2/18 - 11:31 pm
Denali Therapeutics
Parkinson's Disease
Drugs aimed at a sliver of Parkinson’s patients may benefit many more than thought — and boost a biotech
Stat
Wed, 07/25/18 - 03:15 pm
Parkinson's Disease
LRRK2
Pfizer
Denali Therapeutics
GSK
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
RAPS.org
Tue, 05/22/18 - 11:06 am
Alzheimer's disease
FDA
Roche
AstraZeneca
Bioclinica
Eli Lilly
Denali Therapeutics
Denali Therapeutics starts testing novel approach to fight Alzheimer’s
GoinPharma
Wed, 03/21/18 - 09:16 am
Denali Therapeutics
Alzheimer's disease
DNL747
Teva Pharmaceutical
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Alzheimer's disease
Merck
Eli Lilly
Lundbeck
Biogen
Denali Therapeutics
Yumanity Therapeutics
drug development
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases
Xconomy
Tue, 11/14/17 - 07:55 am
Denali Therapeutics
IPOs
Alzheimer's disease
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Wed, 09/30/15 - 09:51 am
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
Pages
« first
‹ previous
1
2